Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the ...
A United States–based Nigerian nurse practitioner and oncology researcher, Edith Declan, has called on the Federal Government ...
The India axillary hyperhidrosis treatment market is projected to expand at a robust 10.1 % CAGR from 2025 to 2035, climbing from an estimated market size of USD 75.2 million in 2025 to a striking USD ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr.
TipRanks on MSN
GSK Enhances Share Buyback Program with Recent Acquisition
GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the purchase of 175,000 of its own ordinary shares as part of its ...
Explore how GLP-1 receptor agonists (GLP-1RAs) are transforming diabetes and obesity care in India through innovative medical ...
GlaxoSmithKline Inc. was registered by Chase Tribble, a consultant with Counsel Public Affairs Inc. for a number of lobbying ...
Catawba County Public Health’s Community Health Workers program was recognized as the recipient of the 2025 GlaxoSmithKline ...
Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
In addition to DZ BANK AG, GlaxoSmithKline also received a Hold from Deutsche Bank ‘s Emmanuel Papadakis in a report issued today. However, yesterday, Bank of America Securities maintained a Sell ...
TipRanks on MSN
GSK Advances Share Buyback Program with Recent Purchase
An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 180,000 of its own ordinary shares as part ...
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results